A sensitive high throughput ELISA for human eosinophil peroxidase

A specific assay to quantify eosinophil degranulation from patient-derived sources

Sergei I. Ochkur, John Dongil Kim, Cheryl A. Protheroe, Dana Colbert, Rachel M. Condjella, Sophie Bersoux, Richard A. Helmers, Redwan Moqbel, Paige Lacy, Elizabeth A. Kelly, Nizar N. Jarjour, Robert Kern, Anju Peters, Robert P. Schleimer, Glenn T. Furuta, Parameswaran Nair, James J. Lee, Nancy A Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Quantitative high throughput assays of eosinophil-mediated activities in fluid samples from patients in a clinical setting have been limited to ELISA assessments for the presence of the prominent granule ribonucleases, ECP and EDN. However, the demonstration that these ribonucleases are expressed by leukocytes other than eosinophils, as well as cells of non-hematopoietic origin, limits the usefulness of these assays. Two novel monoclonal antibodies recognizing eosinophil peroxidase (EPX) were used to develop an eosinophil-specific and sensitive sandwich ELISA. The sensitivity of this EPX-based ELISA was shown to be similar to that of the commercially available ELISA kits for ECP and EDN. More importantly, evidence is also presented confirming that among these granule protein detection options, EPX-based ELISA is the only eosinophil-specific assay. The utility of this high throughput assay to detect released EPX was shown in ex vivo degranulation studies with isolated human eosinophils. In addition, EPX-based ELISA was used to detect and quantify eosinophil degranulation in several in vivo patient settings, including bronchoalveolar lavage fluid obtained following segmental allergen challenge of subjects with allergic asthma, induced sputum derived from respiratory subjects following hypotonic saline inhalation, and nasal lavage of chronic rhinosinusitis patients. This unique EPX-based ELISA thus provides an eosinophil-specific assay that is sensitive, reproducible, and quantitative. In addition, this assay is adaptable to high throughput formats (e.g., automated assays utilizing microtiter plates) using the diverse patient fluid samples typically available in research and clinical settings.

Original languageEnglish (US)
Pages (from-to)10-20
Number of pages11
JournalJournal of Immunological Methods
Volume384
Issue number1-2
DOIs
StatePublished - Oct 31 2012

Fingerprint

Eosinophil Peroxidase
Eosinophils
Enzyme-Linked Immunosorbent Assay
Ribonucleases
Nasal Lavage
Bronchoalveolar Lavage Fluid
Sputum
Allergens
Inhalation
Leukocytes
Asthma
Monoclonal Antibodies

Keywords

  • Allergic inflammation
  • Eosinophilia
  • EPX
  • Granule proteins

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

A sensitive high throughput ELISA for human eosinophil peroxidase : A specific assay to quantify eosinophil degranulation from patient-derived sources. / Ochkur, Sergei I.; Kim, John Dongil; Protheroe, Cheryl A.; Colbert, Dana; Condjella, Rachel M.; Bersoux, Sophie; Helmers, Richard A.; Moqbel, Redwan; Lacy, Paige; Kelly, Elizabeth A.; Jarjour, Nizar N.; Kern, Robert; Peters, Anju; Schleimer, Robert P.; Furuta, Glenn T.; Nair, Parameswaran; Lee, James J.; Lee, Nancy A.

In: Journal of Immunological Methods, Vol. 384, No. 1-2, 31.10.2012, p. 10-20.

Research output: Contribution to journalArticle

Ochkur, SI, Kim, JD, Protheroe, CA, Colbert, D, Condjella, RM, Bersoux, S, Helmers, RA, Moqbel, R, Lacy, P, Kelly, EA, Jarjour, NN, Kern, R, Peters, A, Schleimer, RP, Furuta, GT, Nair, P, Lee, JJ & Lee, NA 2012, 'A sensitive high throughput ELISA for human eosinophil peroxidase: A specific assay to quantify eosinophil degranulation from patient-derived sources', Journal of Immunological Methods, vol. 384, no. 1-2, pp. 10-20. https://doi.org/10.1016/j.jim.2012.06.011
Ochkur, Sergei I. ; Kim, John Dongil ; Protheroe, Cheryl A. ; Colbert, Dana ; Condjella, Rachel M. ; Bersoux, Sophie ; Helmers, Richard A. ; Moqbel, Redwan ; Lacy, Paige ; Kelly, Elizabeth A. ; Jarjour, Nizar N. ; Kern, Robert ; Peters, Anju ; Schleimer, Robert P. ; Furuta, Glenn T. ; Nair, Parameswaran ; Lee, James J. ; Lee, Nancy A. / A sensitive high throughput ELISA for human eosinophil peroxidase : A specific assay to quantify eosinophil degranulation from patient-derived sources. In: Journal of Immunological Methods. 2012 ; Vol. 384, No. 1-2. pp. 10-20.
@article{0aab2c28906649878fec335d39b36266,
title = "A sensitive high throughput ELISA for human eosinophil peroxidase: A specific assay to quantify eosinophil degranulation from patient-derived sources",
abstract = "Quantitative high throughput assays of eosinophil-mediated activities in fluid samples from patients in a clinical setting have been limited to ELISA assessments for the presence of the prominent granule ribonucleases, ECP and EDN. However, the demonstration that these ribonucleases are expressed by leukocytes other than eosinophils, as well as cells of non-hematopoietic origin, limits the usefulness of these assays. Two novel monoclonal antibodies recognizing eosinophil peroxidase (EPX) were used to develop an eosinophil-specific and sensitive sandwich ELISA. The sensitivity of this EPX-based ELISA was shown to be similar to that of the commercially available ELISA kits for ECP and EDN. More importantly, evidence is also presented confirming that among these granule protein detection options, EPX-based ELISA is the only eosinophil-specific assay. The utility of this high throughput assay to detect released EPX was shown in ex vivo degranulation studies with isolated human eosinophils. In addition, EPX-based ELISA was used to detect and quantify eosinophil degranulation in several in vivo patient settings, including bronchoalveolar lavage fluid obtained following segmental allergen challenge of subjects with allergic asthma, induced sputum derived from respiratory subjects following hypotonic saline inhalation, and nasal lavage of chronic rhinosinusitis patients. This unique EPX-based ELISA thus provides an eosinophil-specific assay that is sensitive, reproducible, and quantitative. In addition, this assay is adaptable to high throughput formats (e.g., automated assays utilizing microtiter plates) using the diverse patient fluid samples typically available in research and clinical settings.",
keywords = "Allergic inflammation, Eosinophilia, EPX, Granule proteins",
author = "Ochkur, {Sergei I.} and Kim, {John Dongil} and Protheroe, {Cheryl A.} and Dana Colbert and Condjella, {Rachel M.} and Sophie Bersoux and Helmers, {Richard A.} and Redwan Moqbel and Paige Lacy and Kelly, {Elizabeth A.} and Jarjour, {Nizar N.} and Robert Kern and Anju Peters and Schleimer, {Robert P.} and Furuta, {Glenn T.} and Parameswaran Nair and Lee, {James J.} and Lee, {Nancy A}",
year = "2012",
month = "10",
day = "31",
doi = "10.1016/j.jim.2012.06.011",
language = "English (US)",
volume = "384",
pages = "10--20",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A sensitive high throughput ELISA for human eosinophil peroxidase

T2 - A specific assay to quantify eosinophil degranulation from patient-derived sources

AU - Ochkur, Sergei I.

AU - Kim, John Dongil

AU - Protheroe, Cheryl A.

AU - Colbert, Dana

AU - Condjella, Rachel M.

AU - Bersoux, Sophie

AU - Helmers, Richard A.

AU - Moqbel, Redwan

AU - Lacy, Paige

AU - Kelly, Elizabeth A.

AU - Jarjour, Nizar N.

AU - Kern, Robert

AU - Peters, Anju

AU - Schleimer, Robert P.

AU - Furuta, Glenn T.

AU - Nair, Parameswaran

AU - Lee, James J.

AU - Lee, Nancy A

PY - 2012/10/31

Y1 - 2012/10/31

N2 - Quantitative high throughput assays of eosinophil-mediated activities in fluid samples from patients in a clinical setting have been limited to ELISA assessments for the presence of the prominent granule ribonucleases, ECP and EDN. However, the demonstration that these ribonucleases are expressed by leukocytes other than eosinophils, as well as cells of non-hematopoietic origin, limits the usefulness of these assays. Two novel monoclonal antibodies recognizing eosinophil peroxidase (EPX) were used to develop an eosinophil-specific and sensitive sandwich ELISA. The sensitivity of this EPX-based ELISA was shown to be similar to that of the commercially available ELISA kits for ECP and EDN. More importantly, evidence is also presented confirming that among these granule protein detection options, EPX-based ELISA is the only eosinophil-specific assay. The utility of this high throughput assay to detect released EPX was shown in ex vivo degranulation studies with isolated human eosinophils. In addition, EPX-based ELISA was used to detect and quantify eosinophil degranulation in several in vivo patient settings, including bronchoalveolar lavage fluid obtained following segmental allergen challenge of subjects with allergic asthma, induced sputum derived from respiratory subjects following hypotonic saline inhalation, and nasal lavage of chronic rhinosinusitis patients. This unique EPX-based ELISA thus provides an eosinophil-specific assay that is sensitive, reproducible, and quantitative. In addition, this assay is adaptable to high throughput formats (e.g., automated assays utilizing microtiter plates) using the diverse patient fluid samples typically available in research and clinical settings.

AB - Quantitative high throughput assays of eosinophil-mediated activities in fluid samples from patients in a clinical setting have been limited to ELISA assessments for the presence of the prominent granule ribonucleases, ECP and EDN. However, the demonstration that these ribonucleases are expressed by leukocytes other than eosinophils, as well as cells of non-hematopoietic origin, limits the usefulness of these assays. Two novel monoclonal antibodies recognizing eosinophil peroxidase (EPX) were used to develop an eosinophil-specific and sensitive sandwich ELISA. The sensitivity of this EPX-based ELISA was shown to be similar to that of the commercially available ELISA kits for ECP and EDN. More importantly, evidence is also presented confirming that among these granule protein detection options, EPX-based ELISA is the only eosinophil-specific assay. The utility of this high throughput assay to detect released EPX was shown in ex vivo degranulation studies with isolated human eosinophils. In addition, EPX-based ELISA was used to detect and quantify eosinophil degranulation in several in vivo patient settings, including bronchoalveolar lavage fluid obtained following segmental allergen challenge of subjects with allergic asthma, induced sputum derived from respiratory subjects following hypotonic saline inhalation, and nasal lavage of chronic rhinosinusitis patients. This unique EPX-based ELISA thus provides an eosinophil-specific assay that is sensitive, reproducible, and quantitative. In addition, this assay is adaptable to high throughput formats (e.g., automated assays utilizing microtiter plates) using the diverse patient fluid samples typically available in research and clinical settings.

KW - Allergic inflammation

KW - Eosinophilia

KW - EPX

KW - Granule proteins

UR - http://www.scopus.com/inward/record.url?scp=84865587245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865587245&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2012.06.011

DO - 10.1016/j.jim.2012.06.011

M3 - Article

VL - 384

SP - 10

EP - 20

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -